American International Group’s Aldeyra Therapeutics ALDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-22,952
| Closed | -$75.1K | – | 99 |
|
|
2024
Q1 | $75.1K | Sell |
22,952
-197
| -0.9% | -$644 | ﹤0.01% | 2664 |
|
|
2023
Q4 | $81.3K | Sell |
23,149
-94
| -0.4% | -$330 | ﹤0.01% | 2667 |
|
|
2023
Q3 | $155K | Buy |
23,243
+826
| +4% | +$5.52K | ﹤0.01% | 2257 |
|
|
2023
Q2 | $188K | Buy |
+22,417
| New | +$188K | ﹤0.01% | 2208 |
|
|
2022
Q2 | – | Sell |
-24,096
| Closed | -$107K | – | 3089 |
|
|
2022
Q1 | $107K | Sell |
24,096
-1,696
| -7% | -$7.53K | ﹤0.01% | 2568 |
|
|
2021
Q4 | $103K | Sell |
25,792
-771
| -3% | -$3.08K | ﹤0.01% | 2700 |
|
|
2021
Q3 | $233K | Sell |
26,563
-632
| -2% | -$5.54K | ﹤0.01% | 2342 |
|
|
2021
Q2 | $308 | Buy |
+27,195
| New | +$308 | ﹤0.01% | 2239 |
|
|
2020
Q2 | – | Sell |
-13,576
| Closed | -$34K | – | 3108 |
|
|
2020
Q1 | $34K | Sell |
13,576
-784
| -5% | -$1.96K | ﹤0.01% | 2813 |
|
|
2019
Q4 | $83K | Buy |
14,360
+118
| +0.8% | +$682 | ﹤0.01% | 2716 |
|
|
2019
Q3 | $75K | Sell |
14,242
-98
| -0.7% | -$516 | ﹤0.01% | 2743 |
|
|
2019
Q2 | $86K | Buy |
14,340
+868
| +6% | +$5.21K | ﹤0.01% | 2757 |
|
|
2019
Q1 | $122K | Sell |
13,472
-437
| -3% | -$3.96K | ﹤0.01% | 2506 |
|
|
2018
Q4 | $115K | Buy |
13,909
+2,641
| +23% | +$21.8K | ﹤0.01% | 2515 |
|
|
2018
Q3 | $155K | Buy |
11,268
+895
| +9% | +$12.3K | ﹤0.01% | 2574 |
|
|
2018
Q2 | $82K | Buy |
+10,373
| New | +$82K | ﹤0.01% | 2870 |
|